V

Vesalius Longevity Labs

ActivePharmaceuticals

Legal name: Vesalius Longevity Labs Inc. · Corporation

Vancouver, British Columbia, Canada
$36.6M
Total Raised
2
Form D filings
Oct 2026
First Raise
Nov 2026
Last Raise

From SEC Form D filings. Amounts are totals sold as reported by the company, in USD.

Funding Timeline

Reg D offeringNov 6, 2026
$6.5M raisedOffering size: $13.5M9 investors
Securities: equity, options, convertible
SEC filing File 021-605141
Reg D offeringOct 28, 2026
$30.1M raisedOffering size: $30.1M62 investors
Securities: equity
SEC filing File 021-603399

People

Executive officers, directors and promoters named on the company's SEC Form D filings.

C
Christopher Cooper

Executive Officer

Listed Nov 2026 – Nov 2026Form D
D
David Adelman

Director

Listed Nov 2026 – Nov 2026Form D
J
James McRoberts

Director

Listed Nov 2026 – Nov 2026Form D
J
Joel Leonoff

Director

Listed Nov 2026 – Nov 2026Form D
K
Kevin Mayer

Director

Listed Nov 2026 – Nov 2026Form D
K
Kevin Serre

Director

Listed Nov 2026 – Nov 2026Form D
L
Lee Applbaum

Director

Listed Nov 2026 – Nov 2026Form D
P
Pradeep Albert

Executive Officer

Listed Nov 2026 – Nov 2026Form D
R
Robert McCue

Director

Listed Nov 2026 – Nov 2026Form D
T
Timmi Stump

Executive Officer

Listed Nov 2026 – Nov 2026Form D

Sources

  • SEC Form D
  • SEC CIK2131865